PTGX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:54):
Our systems believe the stock currently is undervalued by 0.24% compare to its pairs and should correct upwards.

Stats
Dagens volum	364 703
Gjennomsnittsvolum	600 029
Markedsverdi	1.87B
EPS	$3.41 ( Q1 \| 2024-05-07 )
Neste inntjeningsdato	( $-0.500 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	12.57 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0590 (0.18%)

AADI -5.88%

ABCL 1.10%

ABCM 0.04%

ABEO -3.08%

ABIO -0.30%

ABOS 1.64%

ABSI 3.74%

ABUS -1.31%

ABVX -3.00%

ACAD -0.51%

ACER -17.95%

ACET -9.39%

ACGN 1.29%

ACHL -1.70%

ACHV 2.59%

ACIU -0.62%

ACLX -0.63%

ACRV -3.80%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -3.79%

ADGI 0.87%

ADIL -2.63%

ADMA -1.23%

ADPT 0.44%

ADTX -3.47%

ADVM 1.01%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -3.15%

AGEN -3.77%

AGIO -2.48%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.21%

AKRO -2.21%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -1.95%

ALEC -0.80%

ALGS -0.37%

ALKS 1.86%

ALLK -11.44%

ALLO -2.50%

ALLR -2.64%

ALNA 3.16%

ALNY 2.20%

ALPN 0.02%

ALPX 0.00%

ALRN -2.17%

ALT -15.05%

ALVR -0.63%

ALXN 0.00%

ALXO -10.50%

ALZN 5.10%

AMRN -4.55%

AMTI -3.13%

ANAB 1.47%

ANEB 7.95%

ANGN 0.00%

ANIX -3.25%

ANL -0.14%

ANNX 3.17%

ANPC -3.15%

APGE 2.08%

APGN 8.48%

APGNW 30.65%

APLM -3.25%

APLS 0.15%

APLT 1.35%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 3.21%

ARAV -13.39%

ARCT -6.81%

ARDS -12.13%

ARDX 2.41%

ARGX -0.96%

ARNA 0.00%

ARPO -0.90%

ARQT -3.65%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.07%

ARWR -2.27%

ASLN -2.45%

ASMB -7.03%

ASND -2.30%

ATAI -3.33%

ATHA 7.76%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 5.83%

ATRA -6.30%

ATXI 1.09%

ATXS -0.34%

AUPH -0.81%

AURA 4.85%

AUTL -3.30%

AVBP -1.83%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -0.68%

AVTX -4.26%

AVXL -5.67%

AXLA 0.00%

AXSM -1.33%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.28%

BCAB -7.17%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.89%

BCTX 13.32%

BCTXW 1.97%

BCYC 0.80%

BDRX -5.55%

BDTX 0.32%

BEAM 2.72%

BFRA -2.91%

BGNE -2.68%

BIOR -3.83%

BIVI 2.13%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -1.07%

BLU 0.03%

BLUE -4.46%

BMEA -14.78%

BMRN 0.07%

BNOX 4.46%

BNTC -2.95%

BNTX -2.23%

BOLD -11.06%

BOLT 0.32%

BPMC -2.35%

BPTH -4.74%

BPTS -13.47%

BRNS -0.37%

BRTX -6.21%

BTAI 12.61%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.78%

CABA 0.83%

CADL 1.42%

CALA 0.00%

CALC -3.82%

CALT -1.59%

CAPR -0.43%

CARA -11.68%

CARM 6.18%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 1.03%

CCCC -1.59%

CCXI 0.00%

CDAK 0.00%

CDIO -4.66%

CDIOW 24.00%

CDMO -1.48%

CDMOP 0.04%

CDT -4.88%

CDTTW -39.60%

CDTX -6.19%

CDXC 9.85%

CDXS 9.66%

CELC -3.18%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.49%

CERO -5.02%

CEROW -10.18%

CFRX -27.95%

CGEM 0.27%

CGEN -3.59%

CGON -2.82%

CGTX -3.41%

CHMA -6.00%

CHRS 5.06%

CINC 0.00%

CING -3.91%

CINGW 34.95%

CKPT -1.68%

CLBS -16.75%

CLDX -0.66%

CLGN -0.50%

CLLS -3.11%

CLNN -2.23%

CLNNW 0.00%

CLRB 6.67%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 2.24%

CMPI 0.00%

CMPX 0.94%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.43%

CNCE 0.00%

CNSP -33.74%

CNST 0.00%

CNTA 0.84%

CNTB -1.50%

CNTX -7.76%

COCP -1.83%

COEPW 32.45%

COGT -2.76%

CORT 3.46%

COYA -2.44%

CPRX -1.42%

CRBP -1.53%

CRBU -7.67%

CRDF 2.43%

CRGX -1.21%

CRIS -2.64%

CRNX -5.95%

CRSP 0.85%

CRTX 2.63%

CRVO -7.45%

CRVS 0.28%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -1.65%

CTNM 5.57%

CTXR -4.87%

CUE -3.11%

CVAC -4.94%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 19.63%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -3.00%

CYTO 0.00%

DARE 0.86%

DAWN -0.11%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 30.97%

DNLI -1.88%

DNTH -2.03%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.42%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -2.92%

EDSA 4.14%

EFTR 1.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.14%

ELEV -1.87%

ELOX 10.77%

ELTX -3.38%

ELVN -1.21%

ELYM 5.86%

ENGN 0.49%

ENGNW -21.67%

ENLV 0.74%

ENOB 1.79%

ENSC 6.55%

ENTA -0.90%

ENTO -4.97%

ENTX -1.60%

ENVB -0.02%

EPIX -0.82%

EPRX -2.87%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 5.84%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -6.11%

ETON 2.44%

ETTX 0.00%

EVAX 0.00%

EVGN 3.46%

EVLO 0.00%

EWTX 0.23%

EXAI -0.38%

EXEL 0.88%

EYEG -0.69%

EYEN 0.00%

EYPT -0.06%

FATE -12.23%

FBIO 0.89%

FBIOP 0.87%

FBLG -10.70%

FBRX -0.04%

FDMT -4.68%

FENC -2.65%

FGEN -9.83%

FHTX 9.16%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.87%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.89%

FULC 2.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -0.77%

GBIO -0.71%

GBT 0.01%

GDTC 2.05%

GERN -1.44%

GHRS -4.27%

GLMD -2.48%

GLPG -1.83%

GLSI 10.66%

GLTO -3.90%

GLUE -2.37%

GLYC -15.04%

GMAB -0.35%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -3.98%

GNPX -4.41%

GNTA 3.94%

GOSS -7.07%

GOVX -6.73%

GOVXW 10.89%

GPCR -5.75%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.20%

GRTX -1.66%

GTHX 2.27%

GUTS 0.69%

GXGXW 41.67%

GYRE -5.95%

HALO -0.80%

HARP 0.09%

HCWB -3.76%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX 0.23%

HOOK 1.17%

HOTH -3.78%

HOWL 0.21%

HRMY 3.35%

HRTX 8.85%

HSTO 0.00%

HUMA 1.62%

HUMAW -6.25%

IBRX -5.91%

ICCC -2.10%

ICPT 0.21%

ICU 19.03%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.21%

IFRX -3.14%

IGMS -1.54%

IKNA -1.79%

IKT -2.08%

IMAB -0.58%

IMCR -3.47%

IMGN 0.02%

IMGO 0.00%

IMMP 5.51%

IMMX -3.04%

IMNM 3.73%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.83%

IMTX -1.33%

IMTXW 6.00%

IMUX -6.42%

IMV 0.00%

IMVT -3.89%

INAB -1.12%

INBX -3.27%

INCY -2.08%

INDP 6.88%

INFI -52.38%

INKT 0.00%

INM 3.06%

INMB 1.82%

INO 1.82%

INSM -0.95%

INTS -3.73%

INVA 0.96%

INZY 1.14%

IOBT -7.09%

IONS 1.51%

IOVA -3.85%

IPA 1.08%

IPHA 2.54%

IPSC -2.34%

IRON -1.75%

ISEE 0.38%

ITOS 2.80%

ITRM 1.36%

IVA 6.96%

IVVD 0.41%

JAGX 0.26%

JANX -4.75%

JAZZ -0.73%

JNCE 0.00%

JSPR -1.83%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.49%

KALV -2.60%

KDNY 0.22%

KMPH -0.34%

KNSA -2.58%

KNTE -0.38%

KOD -8.89%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.33%

KRRO -1.59%

KRTX 0.03%

KRYS 0.99%

KTRA 9.58%

KTTA -0.65%

KTTAW 0.92%

KURA 0.98%

KYMR -3.44%

KYTX -5.56%

KZIA 6.13%

KZR -1.48%

LABP 0.57%

LBPH 0.89%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.76%

LENZ -3.21%

LEXX 0.58%

LEXXW -14.63%

LGND -0.85%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.35%

LPCN -4.36%

LPTX -1.10%

LQDA 0.29%

LRMR -0.50%

LSTA -1.68%

LTRN 5.49%

LUMO 0.67%

LVTX -5.15%

LXEO -13.02%

LXRX -0.88%

LYEL -36.03%

LYRA 4.18%

MACK 0.10%

MBIO -11.98%

MBRX -1.43%

MCRB 0.59%

MDGL -1.71%

MDNA -13.16%

MDWD 3.34%

MDXG -1.40%

MEIP 0.70%

MESO -1.41%

MGNX -5.36%

MGTA -7.74%

MGTX 0.95%

MGX -0.54%

MIRM -0.39%

MIRO 0.59%

MIST 1.92%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 1.05%

MLYS -8.46%

MNKD -0.67%

MNMD 2.97%

MNOV 1.41%

MNPR -9.34%

MOLN 0.76%

MOR 0.62%

MORF -2.95%

MREO 0.14%

MRKR -0.43%

MRNA -10.77%

MRNS -6.62%

MRSN -3.58%

MRTX -0.17%

MRUS 0.81%

MRVI 1.53%

MTCR -1.29%

MTEM 7.43%

MTP -18.50%

MURA -4.64%

MYMD 2.16%

NAMS 0.13%

NAMSW 0.64%

NAUT 0.67%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -0.32%

NEXI 1.50%

NGM -1.28%

NGNE 3.60%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.40%

NKTX -2.69%

NLSP 5.63%

NLSPW 26.67%

NMRA -1.26%

NMTR -42.97%

NOVN -24.84%

NRBO 12.72%

NRIX -1.54%

NRSN 0.78%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.63%

NTRBW -31.07%

NUVL -1.95%

NVAX -5.82%

NVCT -8.45%

NVIV -34.28%

NXTC -6.71%

NYMX -0.05%

OABI 3.03%

OABIW -10.06%

OBIO 0.29%

OBSV 0.00%

OCEA -3.52%

OCGN 6.78%

OCS -1.00%

OCUL 0.69%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.43%

OMER -2.44%

OMGA -2.50%

ONCO 6.17%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.87%

ONTX -0.47%

ONVO 1.01%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -3.26%

ORMP 16.08%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.14%

OVID 0.40%

OYST 0.00%

PALI -0.48%

PASG 0.00%

PBLA -7.50%

PBM -4.75%

PBYI 5.07%

PCSA 0.00%

PCVX 0.72%

PDSB -4.75%

PEPG 1.52%

PGEN -6.59%

PHAR 1.99%

PHAS 0.00%

PHAT 0.10%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.38%

PLUR 10.34%

PMN -5.55%

PMVP -0.89%

PNT 0.16%

PPBT 1.64%

PRAX 4.79%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 1.79%

PRQR 1.20%

PRTA -3.61%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -5.22%

PTCT 0.19%

PTE -0.82%

PTGX 0.71%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.41%

QLGN -5.84%

QNCX 2.23%

QNRX 0.84%

QSI -28.55%

QSIAW -9.44%

QTTB 4.58%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -1.79%

RARE 2.12%

RCKT -10.21%

REGN -0.20%

RENB -3.42%

REPL -2.15%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.35%

RGLS -5.62%

RGNX -6.21%

RIGL -6.25%

RLAY -5.64%

RLMD -0.33%

RLYB -5.70%

RNA 2.67%

RNAC 3.37%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.17%

ROIVW 4.56%

RPHM -2.48%

RPRX -0.80%

RPTX -1.03%

RUBY 2.70%

RVLP -32.05%

RVMD -0.54%

RVMDW -29.90%

RVNC -0.43%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.97%

RYTM -5.56%

RYZB 0.02%

RZLT 3.10%

SABS -1.37%

SABSW -5.53%

SAGE -0.83%

SANA -2.12%

SAVA -4.07%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 1.29%

SCPH 11.62%

SCPS 0.00%

SEEL -3.16%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.04%

SGMT -4.35%

SGTX -2.56%

SIOX 22.63%

SLDB -2.24%

SLGL 5.23%

SLN -8.73%

SLNO 1.64%

SLRX 0.40%

SLS -3.85%

SMMT -3.37%

SNDX 2.10%

SNGX 4.45%

SNPX -2.77%

SONN -1.59%

SPPI -0.49%

SPRB -1.63%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -0.74%

SRRA 0.00%

SRRK -2.60%

SRZN -2.45%

STAB 0.00%

STOK -6.88%

STRO -0.84%

STSA 0.00%

STTK 6.89%

SURF -0.93%

SVRA -1.97%

SWTX -0.14%

SYBX 0.00%

SYRS -1.73%

TALS -0.73%

TARA -7.14%

TARS -2.36%

TBPH 0.30%

TCBP 5.49%

TCDA 0.00%

TCON -1.34%

TCRR 0.00%

TCRT 4.49%

TCRX -2.58%

TECH -1.31%

TENX -0.32%

TERN -6.69%

TFFP -11.17%

TGTX -7.71%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.65%

TNGX -4.21%

TNXP -10.24%

TNYA -6.13%

TPST 4.59%

TRDA -4.77%

TRVI 1.92%

TRVN 3.15%

TSHA -16.72%

TSVT -4.39%

TTNP -6.05%

TVTX 3.83%

TYRA -7.23%

UBX -2.73%

UNCY -4.00%

URGN 3.76%

UTHR -0.41%

VACC 11.36%

VALN -3.15%

VAXX 118.75%

VBIV -0.79%

VBLT -8.77%

VCEL 1.65%

VCNX 5.44%

VCYT -0.97%

VERA -4.34%

VERU 1.40%

VERV -3.54%

VIGL 0.81%

VINC 2.81%

VIR -0.87%

VIRI -5.66%

VIRX 3.47%

VKTX -0.73%

VLON -13.04%

VNDA -3.01%

VOR -6.03%

VRCA 0.43%

VRDN -2.90%

VRNA -1.86%

VRPX 3.58%

VRTX -0.06%

VSTM 4.93%

VTGN -2.26%

VTVT 1.28%

VTYX -2.30%

VXRT -1.19%

VYGR -0.51%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.17%

XBIO 1.03%

XBIT 5.42%

XCUR 0.23%

XENE -0.91%

XERS 4.99%

XFOR 6.25%

XLO 4.47%

XLRN 0.00%

XNCR 0.31%

XOMA -6.99%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.76%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.70%

ZNTL -1.07%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-13	Patel Dinesh V Ph D	Sell	1 000	Common Stock
2024-06-07	Waddill William D.	Buy	8 000	Common Stock
2024-06-07	Waddill William D.	Sell	8 000	Stock Option (right to buy)
2024-06-07	Waddill William D.	Sell	8 000	Common Stock
2024-06-07	Patel Dinesh V Ph D	Sell	35 000	Common Stock

INSIDER POWER
59.83
Last 97 transactions
Buy: 2 539 640 \| Sell: 469 541

Korrelasjon (AI algo v.1.1b): Undervalued: 0.24% $32.02 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.43 (neutral)

Kort: -0.51 (weak negative)

Signal:(74.253) Neutral

Protagonist Therapeutics Korrelasjon

10 Mest positive korrelasjoner
ICFI	0.86
SRTS	0.854
KYMR	0.846
PPH	0.846
CREX	0.833
REYN	0.829
REGN	0.828
EOLS	0.822
MRUS	0.817
LRMR	0.813

10 Mest negative korrelasjoner
VALN	-0.806

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Protagonist Therapeutics Korrelasjon - Valuta/Råvare

0.40
( neutral )

0.30
( neutral )

0.00
( neutral )

0.51
( weak )

-0.33
( neutral )

-0.62
( weak negative )

Protagonist Therapeutics Økonomi

Annual	2023
Omsetning:	$60.00M
Bruttogevinst:	$56.69M (94.48 %)
EPS:	$-1.390

FY	2023
Omsetning:	$60.00M
Bruttogevinst:	$56.69M (94.48 %)
EPS:	$-1.390

FY	2022
Omsetning:	$26.58M
Bruttogevinst:	$25.55M (96.12 %)
EPS:	$-2.52

FY	2021
Omsetning:	$27.36M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.71

Financial Reports:

No articles found.

Protagonist Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Protagonist Therapeutics

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 integrin- specific antagonist peptide that is in Phase II clinical trials for treating inflammatory bowel disease (IBD); and PN-235, an orally delivered interleukin-23 receptor specific antagonist for the treatment of IBD and non-IBD indications. The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.